207 related articles for article (PubMed ID: 36325952)
1. Hydroxychloroquine use reduces mortality risk in systemic lupus erythematosus: A systematic review and meta-analysis of cohort studies.
Cai T; Zhao J; Yang Y; Jiang Y; Zhang JA
Lupus; 2022 Dec; 31(14):1714-1725. PubMed ID: 36325952
[TBL] [Abstract][Full Text] [Related]
2. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
[TBL] [Abstract][Full Text] [Related]
3. Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis.
Duan J; Ma D; Wen X; Guo Q; Gao J; Zhang G; Xu K; Zhang L
Lupus; 2021 Jun; 30(7):1163-1174. PubMed ID: 33853420
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.
Chen YM; Lin CH; Lan TH; Chen HH; Chang SN; Chen YH; Wang JS; Hung WT; Lan JL; Chen DY
Rheumatology (Oxford); 2015 Jul; 54(7):1244-9. PubMed ID: 25587177
[TBL] [Abstract][Full Text] [Related]
5. Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis.
Liu D; Li X; Zhang Y; Kwong JS; Li L; Zhang Y; Xu C; Li Q; Sun X; Tian H; Li S
Drug Des Devel Ther; 2018; 12():1685-1695. PubMed ID: 29928112
[TBL] [Abstract][Full Text] [Related]
6. Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus.
Fasano S; Pierro L; Pantano I; Iudici M; Valentini G
J Rheumatol; 2017 Jul; 44(7):1032-1038. PubMed ID: 28507183
[TBL] [Abstract][Full Text] [Related]
7. Antimalarials may reduce cancer risk in patients with systemic lupus erythematosus: a systematic review and meta-analysis of prospective studies.
Li XB; Cao NW; Chu XJ; Zhou HY; Wang H; Yu SJ; Ye DQ; Li BZ
Ann Med; 2021 Dec; 53(1):1687-1695. PubMed ID: 34553648
[TBL] [Abstract][Full Text] [Related]
8. Identification of new risk factors for hydroxychloroquine and chloroquine retinopathy in systemic lupus erythematosus patients.
Trefond L; Lhote R; Mathian A; de Chambrun MP; Pha M; Hie M; Miyara M; Papo M; Moyon Q; Taieb D; Saade S; Salem TB; Haroche J; Chasset F; Aubart FC; Zahr N; Amoura Z
Semin Arthritis Rheum; 2024 Jun; 66():152417. PubMed ID: 38394986
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine and Mortality Among Patients With Systemic Lupus Erythematosus in the General Population.
Jorge A; McCormick N; Lu N; Zheng Y; Esdaile J; De Vera M; Choi H; Aviña-Zubieta JA
Arthritis Care Res (Hoboken); 2021 Aug; 73(8):1219-1223. PubMed ID: 32407570
[TBL] [Abstract][Full Text] [Related]
10. Favorable effects of hydroxychloroquine on serum low density lipid in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
Babary H; Liu X; Ayatollahi Y; Chen XP; Doo L; Uppaluru LK; Kwak MK; Kulaga C; Modjinou D; Olech E; Yoo JW
Int J Rheum Dis; 2018 Jan; 21(1):84-92. PubMed ID: 28884965
[TBL] [Abstract][Full Text] [Related]
11. The early protective effect of hydroxychloroquine on the risk of cumulative damage in patients with systemic lupus erythematosus.
Akhavan PS; Su J; Lou W; Gladman DD; Urowitz MB; Fortin PR
J Rheumatol; 2013 Jun; 40(6):831-41. PubMed ID: 23588942
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Monitoring Hydroxychloroquine Levels in Patients With Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis.
Garg S; Unnithan R; Hansen KE; Costedoat-Chalumeau N; Bartels CM
Arthritis Care Res (Hoboken); 2021 May; 73(5):707-716. PubMed ID: 32004406
[TBL] [Abstract][Full Text] [Related]
13. Continuation Rate, Safety and Efficacy of Hydroxychloroquine Treatment in a Retrospective Cohort of Systemic Lupus Erythematosus in a Japanese Municipal Hospital.
Hosokawa Y; Oiwa H
Intern Med; 2020 Oct; 59(20):2485-2490. PubMed ID: 32641656
[TBL] [Abstract][Full Text] [Related]
14. Association of antimalarial drugs with decreased overall and cause specific mortality in systemic lupus erythematosus.
Jin Z; Wang F; Pan W; Liu L; Wu M; Hu H; Ding X; Wei H; Zou Y; Qian X; Wang M; Wu J; Tao J; Tan J; Da Z; Zhang M; Li J; Feng X; Sun L
Rheumatology (Oxford); 2021 Apr; 60(4):1774-1783. PubMed ID: 33099642
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine for the prevention of fetal growth restriction and prematurity in lupus pregnancy: A systematic review and meta-analysis.
Guillotin V; Bouhet A; Barnetche T; Richez C; Truchetet ME; Seneschal J; Duffau P; Lazaro E;
Joint Bone Spine; 2018 Dec; 85(6):663-668. PubMed ID: 29631068
[TBL] [Abstract][Full Text] [Related]
16. Hydroxychloroquine Serum Concentrations and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis.
Mok CC; Penn HJ; Chan KL; Tse SM; Langman LJ; Jannetto PJ
Arthritis Care Res (Hoboken); 2016 Sep; 68(9):1295-302. PubMed ID: 26749299
[TBL] [Abstract][Full Text] [Related]
17. Supplemental hydroxychloroquine therapy regulates adipokines in patients with systemic lupus erythematosus with stable disease.
Wakiya R; Ueeda K; Shimada H; Nakashima S; Kameda T; Miyatake N; Kato M; Miyagi T; Sugihara K; Mizusaki M; Mino R; Kadowaki N; Dobashi H
Clin Rheumatol; 2022 Nov; 41(11):3345-3353. PubMed ID: 35849246
[TBL] [Abstract][Full Text] [Related]
18. Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia.
Seo MR; Chae J; Kim YM; Cha HS; Choi SJ; Oh S; Roh CR
Lupus; 2019 May; 28(6):722-730. PubMed ID: 30971164
[TBL] [Abstract][Full Text] [Related]
19. Association of Higher Hydroxychloroquine Blood Levels With Reduced Thrombosis Risk in Systemic Lupus Erythematosus.
Petri M; Konig MF; Li J; Goldman DW
Arthritis Rheumatol; 2021 Jun; 73(6):997-1004. PubMed ID: 33403833
[TBL] [Abstract][Full Text] [Related]
20. Hydroxychloroquine might reduce risk of incident endometriosis in patients with systemic lupus erythematosus: A retrospective population-based cohort study.
Chen FY; Chen SW; Chen X; Huang JY; Ye Z; Wei JC
Lupus; 2021 Sep; 30(10):1609-1616. PubMed ID: 34259057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
